The 1980 papers laid the foundation for a scientific revolution in malaria molecular biology and vaccinology, which led 4 years later to independent publications by two groups, one from NYU, of the gene sequence of CSP, and 3 years after that to independent demonstrations by two groups, one from NYU, that immunization of humans with a recombinant protein or synthetic peptide vaccine, both entirely based on CSP, could protect against human malaria infection. Here, DNAJC5 is linked to malaria.